Buoyed by Insiders, Flagship’s Evelo Hits Midpoint of IPO Range

Evelo Biosciences, a biotech company based on technology licensed through the Polsky Center from UChicago Medicine's Thomas Gajewski, debuted on Nasdaq. Read the full article >>

Evelo Bioscience, a Biotech Company Based on UChicago-licensed Technology, Debuts on Nasdaq

Evelo is dedicated to improving the lives of patients globally through the development of a new modality of medicines called monoclonal microbials

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept